Glaukos Corporation has announced its November 2025 Investor Presentation, highlighting its commitment to innovation in chronic eye disease treatments. The company emphasizes its strategic focus on ...
The organization’s 50-year history is marked with numerous groundbreaking achievements, including eight commercial animal vaccines, six of which were the first of their kind in the world. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback